xylation genes in the human gut. Comput Struct Biotechnol J. 17:1016-19. Vasapolli R, Schütte K, Schulz C, Vital M, Schomburg D, Pieper DH, Vilchez-Vargars R, Malfertheiner P (2019). Analysis of trans
TRAF2. Cell Death Dis. 14(7):480. doi: 10.1038/s41419-023-06014-5 * equal contribution Schlüter D, E. Schulz-Niemand, M. Stein, M. Naumann (2022) Ovarian tumor domain proteases in pathogen infection. Trends
s onset of prion disease in bovine spongiform encephalopathy (BSE) infected macaques; Montag J , Schulz-Schäffer W, Schrod A, Hunsmann G, Motzkus D; Emerg Infect Dis: 19(7):1125-7;2013 Jul Familial Hy [...] of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease; Montag J , Hitt R, Opitz L, Schulz-Schaeffer WJ, Hunsmann G, Motzkus D; Mol Neurodegener:4:36, 2009 Aug Expertise Scientific methods:
Sep;1849(9):1145-54. 9. Vogt C, Hackmann C, Rabner A, Koste L, Santag S, Kati S, Mandel-Gutfreund Y, Schulz TF, Bohne J. ORF57 overcomes the detrimental sequence bias of Kaposi’s sarcoma-associated herpesvirus
22;2019:4508048. doi: 10.1155/2019/4508048. PMID: 31428635 Müller-Deile J, Schenk H, Schroder P, Schulze K, Bolaños-Palmieri P, Siegerist F, Endlich N, Haller H, Schiffer M. Circulating factors cause p
ng the Mode of Action of a novel broadly acting antiviral inhibitor Supervisor: Prof. Dr. Thomas Schulz, Institute of Virology, MHH Academic Background: Oncology, Sichuan University, China Lena Wolpert
difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test . R. Minso, A. Schulz, C. Dopfer, N. Alfeis, A. van Barneveld, L. Makartian-Gyulumyan, G. Hansen, S. Junge, C. Müller,
S2352-3964(20)30260-7 Scholz KH, Lengenfelder B, Thilo C, Jeron A, Stefanow S, Janssens U, Bauersachs J, Schulze PC, Winter KD, Schroder J, Vom Dahl J, von Beckerath N, Seidl K, Friede T, Meyer T. Impact of COVID-19 [...] Re-purposing with a purpose. J Mol Cell Cardiol 2020;146:41-42 DOI: S0022-2828(20)30227-3 Jendrny P, Schulz C, Twele F, Meller S, von Kockritz-Blickwede M, Osterhaus ADME, Ebbers J, Pilchova V, Pink I, Welte [...] Domenico E, Wendisch D, Grasshoff M, Kapellos TS, Beckstette M, Pecht T, Saglam A, Dietrich O, Mei HE, Schulz AR, Conrad C, Kunkel D, Vafadarnejad E, Xu CJ, Horne A, Herbert M, Drews A, Thibeault C, Pfeiffer
Cluster of Excellence are dedicated to COVID-19 / SARS-CoV-2. Projekt leaders are: Prof. Dr. Thomas F. Schulz, Prof. Dr. Gisa Gerold, Prof. Dr. Thomas Pietschmann, Prof. Dr. Gerard Krause, Prof. Dr. Jens Bosse
difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test. R. Minso, A. Schulz, C. Dopfer, N. Alfeis, A. van Barneveld, L. Makartian-Gyulumyan, G. Hansen, S. Junge, C. Müller,